Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2010

01-12-2010 | Original Article

Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values

Authors: Thomas Opladen, Jürgen G. Okun, Peter Burgard, Nenad Blau, Georg F. Hoffmann

Published in: Journal of Inherited Metabolic Disease | Issue 6/2010

Login to get access

Abstract

Objectives

The objectives of this study were to determine the value of phenylalanine (Phe) loading for diagnosing dopa-responsive dystonia (DRD) in children.

Methods

We investigated orally administered Phe loading tests (100 mg/kg) in seven patients with confirmed DRD and 17 pediatric patients with clinically suspected but excluded DRD. Results of Phe, tyrosine (Tyr), and biopterin from plasma and dried blood spot (DBS) analyses were correlated, and pediatric cutoff values established.

Results

The peak Phe concentration following a Phe load in the pediatric DRD population is lower than reported in adults. By using adult cutoff values and either Phe/Try ratios or biopterin concentrations only, false positive and false negative results are frequent. Only the combined analysis of the Phe/Tyr ratio and biopterin concentration is reliable in children. In children with DRD, dried blood Phe/Tyr ratio exceeded 4.6 (plasma Phe/Tyr ratio >5.4) after 2 h and biopterin concentration in dried blood remained below 16.2 nmol/L (plasma biopterin <14 nmol/L) 1 h after Phe challenge.

Conclusions

Phe loading is a useful tool for diagnosing DRD in children. Test duration can be reduced to only 2 h, and specific pediatric cutoff values need to be applied. Simultaneous measurements of the Phe/Tyr ratio and biopterin in plasma or DBS are essential in pediatric patients.
Literature
go back to reference Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45CrossRefPubMed Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54(Suppl 6):S32–S45CrossRefPubMed
go back to reference Thöny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347(Pt 1):1–16CrossRefPubMed Thöny B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347(Pt 1):1–16CrossRefPubMed
go back to reference Nygaard TG (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 60:577–585PubMed Nygaard TG (1993) Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 60:577–585PubMed
go back to reference Grimes DA, Barclay CL, Duff J, Furukawa Y, Lang AE (2002) Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 72:801–804CrossRefPubMed Grimes DA, Barclay CL, Duff J, Furukawa Y, Lang AE (2002) Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 72:801–804CrossRefPubMed
go back to reference Bandmann O, Valente EM, Holmans P et al (1998) Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 44:649–656CrossRefPubMed Bandmann O, Valente EM, Holmans P et al (1998) Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 44:649–656CrossRefPubMed
go back to reference Blau N, Bonafe L, Thöny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74:172–185CrossRefPubMed Blau N, Bonafe L, Thöny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74:172–185CrossRefPubMed
go back to reference Hyland K, Fryburg JS, Wilson WG et al (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48:1290–1297PubMed Hyland K, Fryburg JS, Wilson WG et al (1997) Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 48:1290–1297PubMed
go back to reference Bandmann O, Goertz M, Zschocke J et al (2003) The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 60:700–702PubMed Bandmann O, Goertz M, Zschocke J et al (2003) The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 60:700–702PubMed
go back to reference Saunders-Pullmann R, Blau N, Hyland K et al (2004) Phenyalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab 83:207–212CrossRef Saunders-Pullmann R, Blau N, Hyland K et al (2004) Phenyalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Mol Genet Metab 83:207–212CrossRef
go back to reference Lopez-Laso E, Ormazabal A, Camino R et al (2006) Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency. Clin Biochem 39:893–897CrossRefPubMed Lopez-Laso E, Ormazabal A, Camino R et al (2006) Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency. Clin Biochem 39:893–897CrossRefPubMed
go back to reference Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406CrossRefPubMed Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406CrossRefPubMed
go back to reference Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer-Verlag, Heidelberg, Berlin, pp 665–702CrossRef Blau N, Thöny B (2008) Pterins and related enzymes. In: Blau N, Duran M, Gibson KM (eds) Laboratory guide to the methods in biochemical genetics. Springer-Verlag, Heidelberg, Berlin, pp 665–702CrossRef
go back to reference Zurflüh MR, Giovannini M, Fiori L et al (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86(Suppl 1):S96–S103CrossRefPubMed Zurflüh MR, Giovannini M, Fiori L et al (2005) Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab 86(Suppl 1):S96–S103CrossRefPubMed
go back to reference Blau N, Duran M, Blaskovics Me (2003) In: Physician's Guide to Laboratory Diagnosis of Metabolic Diseases, Chapter 2, 2nd edn. Springer, London, Berlin, pp. 89-106 Blau N, Duran M, Blaskovics Me (2003) In: Physician's Guide to Laboratory Diagnosis of Metabolic Diseases, Chapter 2, 2nd edn. Springer, London, Berlin, pp. 89-106
go back to reference Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N (2001) Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 47:477–485PubMed Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N (2001) Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 47:477–485PubMed
Metadata
Title
Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values
Authors
Thomas Opladen
Jürgen G. Okun
Peter Burgard
Nenad Blau
Georg F. Hoffmann
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9164-9

Other articles of this Issue 6/2010

Journal of Inherited Metabolic Disease 6/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.